NCT04432090View on ClinicalTrials.gov

GPR119 Agonist for Hypoglycemia in Type 1 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

April 21, 2021

Primary Completion Date

August 12, 2023

Study Completion Date

August 12, 2023

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Placebo

Each group will receive either a pill that contains the study medication (MBX-2982) or a pill that does not contain the medication (placebo)

DRUG

Study Medication (MBX-2982)

Each group will receive either a pill that contains the study medication (MBX-2982) or a pill that does not contain the medication (placebo)

OTHER

No medication for this group

This group will be studied to establish the norm of the measurement that will be performed to obtain the study outcomes.

Trial Locations (1)

32804

AdventHealth Translational Research Institute, Orlando

All Listed Sponsors
lead

AdventHealth Translational Research Institute

OTHER